Tanjina Kader

535 total citations
10 papers, 205 citations indexed

About

Tanjina Kader is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Tanjina Kader has authored 10 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 4 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in Tanjina Kader's work include Cancer Genomics and Diagnostics (5 papers), Genomic variations and chromosomal abnormalities (3 papers) and Breast Lesions and Carcinomas (3 papers). Tanjina Kader is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Genomic variations and chromosomal abnormalities (3 papers) and Breast Lesions and Carcinomas (3 papers). Tanjina Kader collaborates with scholars based in Australia, United Kingdom and New Zealand. Tanjina Kader's co-authors include Kylie L. Gorringe, Ian Campbell, Emad A. Rakha, Prue Hill, Carolyn M. Porteous, Sally P.A. McCormick, Steven P. Gieseg, Michael Williams, Stephen B. Fox and Andrew R. Green and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Genome biology.

In The Last Decade

Tanjina Kader

10 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanjina Kader Australia 9 97 60 57 53 25 10 205
Irianiwati Widodo Indonesia 8 124 1.3× 131 2.2× 74 1.3× 36 0.7× 13 0.5× 41 260
Rin Nagaoka Japan 8 67 0.7× 74 1.2× 31 0.5× 30 0.6× 45 1.8× 16 184
T. Vandorpe Belgium 6 102 1.1× 113 1.9× 56 1.0× 105 2.0× 12 0.5× 10 242
Jin Hong China 11 99 1.0× 123 2.0× 52 0.9× 29 0.5× 21 0.8× 23 229
Alexandra Papathoma Greece 9 59 0.6× 78 1.3× 127 2.2× 18 0.3× 49 2.0× 12 272
Bożena Lackowska Poland 7 73 0.8× 44 0.7× 214 3.8× 96 1.8× 37 1.5× 15 352
Lili Du United States 10 80 0.8× 92 1.5× 160 2.8× 23 0.4× 11 0.4× 27 250
Marianne L. T. van der Sterre Netherlands 10 108 1.1× 43 0.7× 194 3.4× 22 0.4× 14 0.6× 11 280
Lara M. Munín Sánchez Spain 10 21 0.2× 173 2.9× 80 1.4× 75 1.4× 17 0.7× 17 302
Erika Bågeman Sweden 8 47 0.5× 129 2.1× 64 1.1× 21 0.4× 26 1.0× 14 286

Countries citing papers authored by Tanjina Kader

Since Specialization
Citations

This map shows the geographic impact of Tanjina Kader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanjina Kader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanjina Kader more than expected).

Fields of papers citing papers by Tanjina Kader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanjina Kader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanjina Kader. The network helps show where Tanjina Kader may publish in the future.

Co-authorship network of co-authors of Tanjina Kader

This figure shows the co-authorship network connecting the top 25 collaborators of Tanjina Kader. A scholar is included among the top collaborators of Tanjina Kader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanjina Kader. Tanjina Kader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kader, Tanjina, Magnus Zethoven, & Kylie L. Gorringe. (2022). Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything. Genome biology. 23(1). 43–43. 8 indexed citations
2.
Kader, Tanjina, Kenji M. Fujihara, Kylie L. Gorringe, et al.. (2021). Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus. Cellular and Molecular Gastroenterology and Hepatology. 12(2). 689–713. 10 indexed citations
3.
Cheasley, Dane, Lisa Devereux, Siobhan Hughes, et al.. (2020). The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density. npj Breast Cancer. 6(1). 34–34. 6 indexed citations
4.
Kader, Tanjina, Carolyn M. Porteous, Gregory T. Jones, et al.. (2020). Ribose-cysteine protects against the development of atherosclerosis in apoE-deficient mice. PLoS ONE. 15(2). e0228415–e0228415. 10 indexed citations
5.
Toss, Michael S., Chitra Joseph, Tanjina Kader, et al.. (2020). The prognostic significance of immune microenvironment in breast ductal carcinoma in situ. British Journal of Cancer. 122(10). 1496–1506. 32 indexed citations
6.
Kader, Tanjina, Kenneth Elder, Magnus Zethoven, et al.. (2020). The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma. npj Breast Cancer. 6(1). 9–9. 13 indexed citations
7.
Kader, Tanjina, Prue Hill, Magnus Zethoven, et al.. (2019). Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma. The Journal of Pathology. 248(3). 326–338. 21 indexed citations
8.
Kader, Tanjina, Prue Hill, Emad A. Rakha, Ian Campbell, & Kylie L. Gorringe. (2018). Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape. Breast Cancer Research. 20(1). 39–39. 41 indexed citations
9.
Kader, Tanjina, David L. Goode, Stephen Q. Wong, et al.. (2016). Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue. Genome Medicine. 8(1). 121–121. 34 indexed citations
10.
Kader, Tanjina, Carolyn M. Porteous, Michael Williams, Steven P. Gieseg, & Sally P.A. McCormick. (2014). Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice. Atherosclerosis. 237(2). 725–733. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irianiwati Widodo Breakdown of academic impact, for papers by Rin Nagaoka Breakdown of academic impact, for papers by T. Vandorpe Breakdown of academic impact, for papers by Jin Hong Breakdown of academic impact, for papers by Alexandra Papathoma Breakdown of academic impact, for papers by Bożena Lackowska Breakdown of academic impact, for papers by Lili Du Breakdown of academic impact, for papers by Marianne L. T. van der Sterre Breakdown of academic impact, for papers by Lara M. Munín Sánchez Breakdown of academic impact, for papers by Erika Bågeman
Rankless by CCL
2026